Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases

Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study

(2017) Giovanni L. Romano et al.   Frontiers in Pharmacology

TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers

(2016) Vincenzo Fisichella et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Recent perspectives on the delivery of biologics to back of the eye

(2016) Mary Joseph et al.   Expert Opinion on Drug Delivery

Topical delivery of aqueous micellar resolvin E1 analog (RX-10045)

(2016) Kishore Cholkar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

(2015) Marc-Antoine Lauzon et al.   CELLULAR SIGNALLING

Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review

(2015) Fabien Bévalot et al.   Forensic Toxicology

AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures

(2015) Rafael Zambrano et al.   NUCLEIC ACIDS RESEARCH

Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery

(2015) Kishore Cholkar et al.   Translational Vision Science & Technology

Protection of TGF-β1 against Neuroinflammation and Neurodegeneration in Aβ1–42-Induced Alzheimer’s Disease Model Rats

(2015) Jia-Hui Chen et al.   PLoS One

Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery

(2014) Kishore Cholkar et al.   AAPS PHARMSCITECH

Pharmacokinetic studies and LC–MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats

(2014) Sriram Gunda et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion

(2014) R Tuuminen et al.   EYE

Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes

(2014) Benjamin M. Davis et al.   Small

Aqueous Nanomicellar Formulation for Topical Delivery of Biotinylated Lipid Prodrug of Acyclovir: Formulation Development and Ocular Biocompatibility

(2013) Aswani Dutt Vadlapudi et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Suppression of Alzheimer’s Disease-Related Phenotypes by Geranylgeranylacetone in Mice

(2013) Tatsuya Hoshino et al.   PLoS One

Bioanalytical method validation of rapamycin in ocular matrix by QTRAP LC–MS/MS: Application to rabbit anterior tissue distribution by topical administration of rapamycin nanomicellar formulation

(2012) Ravinder Earla et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection

(2011) Filippo Caraci et al.   CELL AND TISSUE RESEARCH

Imaging apoptosis in the eye

(2011) M F Cordeiro et al.   EYE

TGF-β signaling is required for maintenance of retinal ganglion cell differentiation and survival

(2011) T.E. Walshe et al.   NEUROSCIENCE

Ocular penetration of topically applied linezolid in a rabbit model

(2010) Maher Saleh et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer’s disease patients

(2010) B. Juraskova et al.   Journal of Nutrition Health & Aging

TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

(2008) Filippo Caraci et al.   NEUROBIOLOGY OF DISEASE

TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts

(2008) F CARACI et al.   PHARMACOLOGICAL RESEARCH